Niklas Loman
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Genetics 45
- BRCA gene mutations in cancer 44
- Genomic variations and chromosomal abnormalities 8
-
- Cancer Genomics and Diagnostics 10
- Co-authors
- Michael Leonard Friedlander (4 shared papers)M. William Audeh (4 shared papers)Åke Borg (19 shared papers)Hakan Lars Olsson (17 shared papers)Clare Scott (2 shared papers)Andrew N.J. Tutt (2 shared papers)James Carmichael (1 shared paper)Karen H. Lu (1 shared paper)
- Journals
- Breast Cancer Research and Treatment (10 papers)European Journal of Cancer (5 papers)Annals of Oncology (4 papers)Breast Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Niklas Loman
72 papers receiving 11.0k citations
Niklas Loman's Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 4.8k
- Cancer Research 2.6k
- Genetics 4.8k
- Reproductive Medicine 1.4k
- Pathology and Forensic Medicine 1.1k
Countries citing papers authored by Niklas Loman
This map shows the geographic impact of Niklas Loman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niklas Loman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niklas Loman more than expected).
Fields of papers citing papers by Niklas Loman
This network shows the impact of papers produced by Niklas Loman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niklas Loman. The network helps show where Niklas Loman may publish in the future.
Co-authors
The 25 scholars most cited alongside Niklas Loman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies Hit paper breakdown → | 2003 | 2866 |
| 2 | Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial Hit paper breakdown → | 2010 | 1956 |
| 3 | Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation Hit paper breakdown → | 2014 | 1426 |
| 4 | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 461 |
| 5 | An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression Hit paper breakdown → | 2017 | 442 |
| 6 | Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer Hit paper breakdown → | 2015 | 397 |
| 7 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Hit paper breakdown → | 2022 | 321 |
| 8 | 2015 | 253 | |
| 9 | 2001 | 205 | |
| 10 | 2013 | 202 | |
| 11 | 2005 | 163 | |
| 12 | 2010 | 157 | |
| 13 | 1998 | 156 | |
| 14 | 2003 | 154 | |
| 15 | Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. | 1997 | 152 |
| 16 | BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. | 1998 | 126 |
| 17 | 2015 | 121 | |
| 18 | 2016 | 121 | |
| 19 | 1998 | 108 | |
| 20 | 2014 | 105 |
About Niklas Loman
Niklas Loman is a scholar working on Genetics, Cancer Research, Oncology, Reproductive Medicine and Molecular Biology, having authored 72 papers that have together received 11.4k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (44 papers), Cancer Genomics and Diagnostics (10 papers), DNA Repair Mechanisms (10 papers), Genomic variations and chromosomal abnormalities (8 papers), PARP inhibition in cancer therapy (8 papers), Ovarian cancer diagnosis and treatment (7 papers), HER2/EGFR in Cancer Research (4 papers) and Male Breast Health Studies (4 papers). The work is most often cited by research in Oncology (4.8k citations), Cancer Research (2.6k citations), Genetics (4.8k citations), Reproductive Medicine (1.4k citations) and Pathology and Forensic Medicine (1.1k citations). Niklas Loman has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Michael Leonard Friedlander, M. William Audeh, Åke Borg, Hakan Lars Olsson, Clare Scott, Andrew N.J. Tutt, James Carmichael, Karen H. Lu, Mark Wickens and Richard T. Penson. Their work appears in journals such as Breast Cancer Research and Treatment, European Journal of Cancer, Annals of Oncology, Breast Cancer Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.